Home › Funds › LETKO, BROSSEAU & ASSOCIATES INC › GEHC
LETKO, BROSSEAU & ASSOCIATES INC position in GEHC
GE HEALTHCARE TECHNOLOGIES I · Health Care
LETKO, BROSSEAU & ASSOCIATES INC reported holding 884,005 shares of GEHC (GE HEALTHCARE TECHNOLOGIES I) in its Q3 2026 13F filing — a position valued at US$57.8M, representing 0.84% of its reported portfolio and ranking #44 among its reported holdings. LETKO, BROSSEAU & ASSOCIATES INC has disclosed GEHC holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How LETKO, BROSSEAU & ASSOCIATES INC's GEHC position evolved
LETKO, BROSSEAU & ASSOCIATES INC first disclosed a stake in GEHC in Q2 2026 at 878,575 shares (US$56.2M). The position peaked in Q3 2026 at 884,005 shares, worth US$57.8M. Across 2 filings, LETKO, BROSSEAU & ASSOCIATES INC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 884,005 shares valued at US$57.8M — an increase of 5,430 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 878.58K | $56.24M | New |
| Q3 2026 | 884.00K | $57.79M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GEHC and 13F data
GEHC (GE HEALTHCARE TECHNOLOGIES I) is a Health Care company. 27 other funds we track also report a position in GEHC — the largest reported positions include Dodge & Cox (US$2.42B), DODGE & COX (US$2.42B), Harris Associates (Oakmark) (US$981.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GEHC
- Dodge & Cox 37.86M sh · $2.42B · Q2 2026
- DODGE & COX 37.86M sh · $2.42B · Q2 2026
- Harris Associates (Oakmark) 15.33M sh · $981.25M · Q2 2026
- HARRIS ASSOCIATES L P 15.33M sh · $981.25M · Q2 2026
- BARROW HANLEY MEWHINNEY & STRAUSS LLC 13.77M sh · $900.14M · Q3 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 12.25M sh · $784.15M · Q2 2026
- TRIAN FUND MANAGEMENT, L.P. 3.09M sh · $197.49M · Q2 2026
More on LETKO, BROSSEAU & ASSOCIATES INC
FAQ
How long has LETKO, BROSSEAU & ASSOCIATES INC held GEHC?
LETKO, BROSSEAU & ASSOCIATES INC has disclosed GEHC holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is LETKO, BROSSEAU & ASSOCIATES INC's current position in GEHC?
As of Q3 2026, LETKO, BROSSEAU & ASSOCIATES INC holds 884.00K shares of GEHC (GE HEALTHCARE TECHNOLOGIES I), valued at $57.79M, representing 0.84% of its reported portfolio and ranking #44.
Has LETKO, BROSSEAU & ASSOCIATES INC been buying or selling GEHC?
In the latest 13F filing (Q3 2026), LETKO, BROSSEAU & ASSOCIATES INC increased its position in GEHC. The position peaked in Q3 2026 at 884.00K shares.
Which other funds hold GEHC?
Other major institutional holders of GEHC include Dodge & Cox, DODGE & COX, Harris Associates (Oakmark), among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.